Greenbrook: Funding, Investors & Team (Oct 2026)
Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.
Greenbrook has raised $13.9M across 5 funding rounds on record, the most recent an undisclosed round of $1.2M announced in Feb 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Greenbrook Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Greenbrook Funding Rounds
Greenbrook raised $2.8M in an undisclosed round announced in Feb 2023.
5 months later, an undisclosed round of $4.4M was announced in Jul 2023.
3 months later, an undisclosed round of $1.5M was announced in Oct 2023.
2 months later, an undisclosed round of $4.0M was announced in Dec 2023.
2 months later, an undisclosed round of $1.2M was announced in Feb 2024.
Greenbrook Founders and Leadership Team
Contact details for the Greenbrook team: 1 of 2 have an email address on file.
Start 14-day free trial →Greenbrook Funding Compared to Other Biotechnology Startups
Greenbrook's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Greenbrook in Biotechnology and Mclean
Companies Similar to Greenbrook
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Greenbrook Funding FAQs
What does Greenbrook do?
Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.
How much funding has Greenbrook raised?
Greenbrook has raised $13.9M across 5 rounds on record. The most recent is an undisclosed round of $1.2M announced in Feb 2024.
When did Greenbrook last raise funding?
Greenbrook's most recent funding round on record is an undisclosed round of $1.2M, announced in Feb 2024.
Who is the CEO of Greenbrook?
Bill Leonard is listed as CEO at Greenbrook.
Where is Greenbrook headquartered?
Greenbrook is based in Mclean, Virginia, United States.
How many employees does Greenbrook have?
Greenbrook is in the 251-500 employee band.
How does Greenbrook's funding compare to other Biotechnology startups?
Greenbrook's latest round of $1.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Greenbrook Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Greenbrook is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.